Phenylbutazone Market Report 2025 (Global Edition)

Global Phenylbutazone Market Report 2025 Market Size Split by Function (Antipyresis, Analgesia, Pain Relief), by Type (Generic, Branded), by Form (Tablet, Others), by Application (In Humans, In Horses...

Phenylbutazone Market Report Description

We have various report editions of Phenylbutazone Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Impact of Tariff Trumph on Pharmaceuticals Industry

The reintroduction of tariffs under President Trump’s “Liberation Day Tariffs” in April 2025 has created significant disruption in global pharmaceutical trade. These tariffs, ranging from 10% to 46%, specifically target pharmaceutical products, APIs (active pharmaceutical ingredients), medical packaging, and machinery from key manufacturers in China and India. This has led to increased production costs, supply chain delays, and regulatory challenges for U.S.-based pharmaceutical companies.

The tariffs have particularly impacted generic drug manufacturers, who rely heavily on APIs from China and India. Biopharmaceuticals and vaccines are also feeling the pressure, with tariffs on critical materials like bioproduction media and cold-chain packaging raising costs by up to 25%. Similarly, contract manufacturing organizations (CMOs) are grappling with the need to identify new suppliers and adjust production plans to mitigate rising costs.

Foreign governments, including the European Union, have retaliated with tariffs on U.S. pharmaceutical exports, further complicating global trade. Clinical trials are also impacted, as tariffs on drugs and diagnostic kits delay trial timelines.

Market research is increasingly crucial for navigating these challenges. By providing real-time data on API pricing, supplier reliability, and tariff impact, pharmaceutical firms can make informed decisions on sourcing, compliance, and investment strategies. This data-driven approach helps mitigate risks, optimize supply chains, and identify alternative manufacturing hubs to offset tariff-related disruptions.

Overall, market research is essential for pharmaceutical companies to adapt to the new tariff landscape, enabling them to maintain competitive advantage and navigate global trade dynamics effectively.

Phenylbutazone Market Insights Video

Competitive Landscape of the Phenylbutazone Market

The competitive landscape of the Phenylbutazone market is characterized by the presence of several key players, including Merck & Co., Teva Pharmaceutical Industries, and Mylan N.V. These companies compete based on factors such as product efficacy, safety profile, pricing, and distribution network. Additionally, there is a growing focus on research and development activities to enhance drug formulations and explore new therapeutic applications. Market dynamics are also influenced by regulatory factors, patent expirations, and emerging trends in pain management therapies.

October 2022: Glenmark's American subsidiary introduced generic Fingolimod capsules, designed to address multiple sclerosis, into the US market. (Source: https://www.prnewswire.com/news-releases/glenmark-pharmaceuticals-launches-fingolimod-capsules-0-5-mg-in-the-us-301663402.html#:~:text=MUMBAI%2C%20India%20and%20MAHWAH%2C%20N.J.,mg%2C%20of%20Novartis%20Pharmaceuticals%20Corporation. )

In December 2023, AMGIS Lifescience Ltd., an Indian API manufacturer, announced the launch of bulk production of phenylbutazone active pharmaceutical ingredients (APIs) in compliance with USP, BP, and EP standards. The company emphasized its commitment to quality healthcare by offering cost-efficient phenylbutazone APIs for veterinary use, particularly targeting the equine industry.
(Source - https://www.amgislifescience.com/ )
 

Top Companies Market Share in Phenylbutazone Industry: (In no particular order of Rank)

• Merck & Co.
• Inc. (USA)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Mylan N.V. (USA)
• Pfizer Inc. (USA)
• Novartis International AG (Switzerland)
• GlaxoSmithKline plc (UK)
• Sanofi S.A. (France)
• Boehringer Ingelheim GmbH (Germany)
• Bayer AG (Germany)
• Sun Pharmaceutical Industries Ltd. (India)
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Phenylbutazone Market

Which Region Dominates the Phenylbutazone Market in 2024?

According to Cognitive Market Research, North America dominates the Phenylbutazone market due to several factors. The region boasts advanced healthcare infrastructure, high prevalence of inflammatory conditions, and a large aging population. Additionally, extensive research and development activities, coupled with robust regulatory frameworks, contribute to the availability and accessibility of Phenylbutazone-based medications. Furthermore, strategic partnerships between pharmaceutical companies and healthcare providers drive market growth. Overall, these factors culminate in North America capturing the largest market share in the Phenylbutazone market.

Which Region is Expanding at the Fastest CAGR?

The Asia Pacific region is experiencing the fastest Compound Annual Growth Rate (CAGR) in the Phenylbutazone market due to several factors. These include the rising incidence of inflammatory conditions, increasing healthcare expenditure, and expanding geriatric population. Additionally, improving access to healthcare services, growing awareness about pain management therapies, and the presence of emerging economies with favorable regulatory environments contribute to the region's rapid market growth. Overall, these dynamics position the Asia Pacific region as a key growth hub for the Phenylbutazone market.

 

The current report Scope analyzes Phenylbutazone Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (Nigeria, South Africa, Rest of Africa)

The above graph is for illustrative purposes only.

North America Phenylbutazone Market Analysis

According to Cognitive Market Research, the global Phenylbutazone market size was estimated at USD xx Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD xx million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.1% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Phenylbutazone market with a market size of USD xx million in 2024 and is projected to grow at a CAGR of 2.9% during the forecast period. The demand is amplified by the nation's advanced healthcare infrastructure.
• The Canada Phenylbutazone market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 3.9% during the forecast period. This is due to a high prevalence of inflammatory conditions.
• The Mexico Phenylbutazone market is projected to witness growth at a CAGR of 3.6% during the forecast period, with a market size of USD xx million in 2024.

Europe Phenylbutazone Market Analysis

According to Cognitive Market Research, the global Phenylbutazone market size was estimated at USD xx Million out of which Europe held the market of more than 30% of the global revenue with a market size of USD xx million in 2024 and will grow at a compound annual growth rate (CAGR) of 2.5% from 2024 to 2031.

• The United Kingdom Phenylbutazone market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 4.2% during the forecast period. In the UK, Phenylbutazone sales witness an upswing due to rising healthcare expenditure.
• The France Phenylbutazone market is projected to witness growth at a CAGR of 2.6% during the forecast period, with a market size of USD xx million in 2024.
• According to Cognitive Market Research, the Germany Phenylbutazone market size was valued at USD xx million in 2024 and is projected to grow at a CAGR of 3.6% during the forecast period. In Germany, Phenylbutazone sales surged due to advancements in healthcare infrastructure.
• The Italy Phenylbutazone market is projected to witness growth at a CAGR of 2.8% during the forecast period, with a market size of USD xx million in 2024.
• The Russia Phenylbutazone market is projected to witness growth at a CAGR of 2.4% during the forecast period, with a market size of USD xx million in 2024.
• The Spain Phenylbutazone market is projected to witness growth at a CAGR of 2.5% during the forecast period with a market size of USD xx million in 2024
• The Luxembourg Phenylbutazone market is projected to witness growth at a CAGR of 3.5% during the forecast period, with a market size of USD xx million in 2024.
• The Portugal Phenylbutazone market is projected to witness growth at a CAGR of 3.2% during the forecast period, with a market size of USD xx million in 2024.
• The Greece Phenylbutazone market is projected to witness growth at a CAGR of 3.7% during the forecast period, with a market size of USD xx million in 2024.
• Rest of Europe's Phenylbutazone market is projected to witness growth at a CAGR of 2.1% during the forecast period, with a market size of USD xx million in 2024.

Asia Pacific Phenylbutazone Market Analysis

According to Cognitive Market Research, the global Phenylbutazone market size was estimated at USD xx Million, out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD xx million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.9% from 2024 to 2031.

• According to Cognitive Market Research, the China Phenylbutazone market size was valued at USD xx million in 2024 and is projected to grow at a CAGR of 6.4% during the forecast period. Phenylbutazone sales surge in China due to region's rapid market growth.
• The Japan Phenylbutazone market is projected to witness growth at a CAGR of 5.4% during the forecast period, with a market size of USD xx million in 2024.
• The India Phenylbutazone market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 8.7% during the forecast period. This is due to increasing healthcare spending.
• The South Korea Phenylbutazone market is projected to witness growth at a CAGR of 6.0% during the forecast period, with a market size of USD xx million in 2024.
• The Australia Phenylbutazone market is projected to witness growth at a CAGR of 6.6% during the forecast period, with a market size of USD xx million in 2024.
• The South East Asia Phenylbutazone market is projected to witness growth at a CAGR of 7.9% during the forecast period, with a market size of USD xx million in 2024.
• The Rest of Asia Pacific Phenylbutazone market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD xx million in 2024.

South America Phenylbutazone Market Analysis

According to Cognitive Market Research, the global Phenylbutazone market size was estimated at USD xx Million out of which Latin America market of more than 5% of the global revenue with a market size of USD xx million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.3% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Phenylbutazone market size was valued at USD xx million in 2024 and is projected to grow at a CAGR of 4.9% during the forecast period. Phenylbutazone sales flourish in Brazil due to region's large population base.
• Argentina Phenylbutazone market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 5.2% during the forecast period. This is due to increasing healthcare infrastructure development.
• Colombia Phenylbutazone market is projected to witness growth at a CAGR of 4.1% during the forecast period with a market size of USD xx million in 2024.
• Peru Phenylbutazone market is projected to witness growth at a CAGR of 4.5% during the forecast period with a market size of USD xx million in 2024.
• Chile Phenylbutazone market is projected to witness growth at a CAGR of 4.6% during the forecast period with a market size of USD xx million in 2024.
• The Rest of Latin America Phenylbutazone market is projected to witness growth at a CAGR of 3.4% during the forecast period, with a market size of USD xx million in 2024.

Middle East Phenylbutazone Market Analysis

According to Cognitive Market Research, the global Phenylbutazone market size was estimated at USD xx Million, out of which the Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD xx million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.6% from 2024 to 2031.

• The GCC Countries Phenylbutazone market is projected to witness growth at a CAGR of 5.4% during the forecast period with a market size of USD xx million in 2024. Phenylbutazone sales flourish due to improving healthcare infrastructure.
• The Egypt Phenylbutazone market is projected to witness growth at a CAGR of 4.9% during the forecast period, with a market size of USD xx million in 2024.
• The South Africa Phenylbutazone market is projected to witness growth at a CAGR of 5.6% during the forecast period, with a market size of USD xx million in 2024. Phenylbutazone sales flourish in South Africa due to increasing access to medical services.
• The Turkey Phenylbutazone market is projected to witness growth at a CAGR of 4.1% during the forecast period, with a market size of USD xx million in 2024.
• The Nigeria Phenylbutazone market is projected to witness growth at a CAGR of 3.7% during the forecast period, with a market size of USD xx million in 2024.
• The Rest of MEA Phenylbutazone market is projected to witness growth at a CAGR of 3.6% during the forecast period, with a market size of USD xx million in 2024.

Phenylbutazone Market Analysis

Phenylbutazone Market Function Segment Analysis

According to Cognitive Market Research, Antipyresis stands out as the dominating category. The antipyretic function has captured the largest market share in the Phenylbutazone market due to its widespread use in fever management. Phenylbutazone's ability to effectively reduce fever, in addition to its anti-inflammatory properties, makes it a versatile medication for treating various conditions. Healthcare providers often prescribe Phenylbutazone for fever reduction in addition to its primary indication for pain and inflammation. As a result, the antipyretic function dominates the market share, reflecting its significant role in clinical practice.

The analgesic function is experiencing the highest Compound Annual Growth Rate (CAGR) in the Phenylbutazone market due to its increasing demand for pain management. Phenylbutazone's potent analgesic properties make it a preferred choice for treating various painful conditions, including arthritis and musculoskeletal disorders. As the global population ages and the prevalence of chronic pain rises, there is a growing need for effective analgesic medications like Phenylbutazone. This trend is driving the rapid growth of the analgesia function in the Phenylbutazone market.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Phenylbutazone Industry. Request a Free Sample PDF!

Phenylbutazone Market Type Segment Analysis

According to Cognitive Market Research, the dominating category is Generic. The Generic type has captured the largest market share in the Phenylbutazone market due to several factors. Generic Phenylbutazone offers cost-effective alternatives to branded counterparts, making them more accessible to healthcare providers and patients. Additionally, the expiration of patents on branded formulations has led to an influx of generic options, intensifying competition and driving market penetration. Moreover, generic manufacturers often benefit from streamlined regulatory pathways, enabling faster market entry and wider distribution, further contributing to their dominance in the market.

The Branded type is experiencing the highest Compound Annual Growth Rate (CAGR) in the Phenylbutazone market due to several factors. Branded Phenylbutazone medications often offer enhanced formulations, innovative delivery systems, and strong brand recognition, which appeal to healthcare providers and patients seeking high-quality and trusted products. Additionally, strategic marketing initiatives, targeted promotional campaigns, and investments in research and development contribute to the sustained growth of branded Phenylbutazone products, positioning them for higher market acceptance and adoption.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Phenylbutazone Form Segment Analysis

Form Segment Analysis

According to Cognitive Market Research, the dominating category is Tablet. Tablet form has captured the largest market share in the Phenylbutazone market due to its convenience, ease of administration, and widespread acceptance among healthcare providers and patients. Tablets offer precise dosing, consistent efficacy, and convenient storage, making them a preferred choice for oral drug delivery. Additionally, the availability of various strengths and formulations of Phenylbutazone tablets caters to diverse patient needs. This dominance is further bolstered by the familiarity and established manufacturing capabilities of pharmaceutical companies in producing tablet formulations.

The Others form is experiencing the highest Compound Annual Growth Rate (CAGR) in the Phenylbutazone market due to several factors. This category encompasses alternative formulations such as injectables, topical creams, and suspensions, offering diverse options for drug delivery and administration. These alternative forms cater to patient preferences, especially in cases where oral administration is not feasible or effective. Moreover, innovations in drug delivery technologies and formulations contribute to the increased adoption of other forms of Phenylbutazone, driving their rapid market growth.

• Tablet
• Others

Phenylbutazone Application Segment Analysis

Application Segment Analysis

According to Cognitive Market Research, the dominating category is In Humans. The In Humans application has captured the largest market share in the Phenylbutazone market due to its extensive use in treating various inflammatory conditions and pain management in humans. Phenylbutazone's effectiveness in alleviating pain and reducing inflammation makes it a widely prescribed medication by healthcare providers. Additionally, the rising prevalence of inflammatory disorders, coupled with an aging population and increasing awareness about pain management therapies, further contribute to the dominance of the In Humans application in the market.

The In Horses application is experiencing the highest Compound Annual Growth Rate (CAGR) in the Phenylbutazone market due to several factors. Phenylbutazone is commonly used in veterinary medicine to alleviate pain and inflammation in horses, particularly for conditions such as lameness and arthritis. The growing demand for equine healthcare services, increasing pet ownership, and expanding equestrian sports industry contribute to the rising adoption of Phenylbutazone in the In Horses application, driving its rapid market growth.

• In Humans
• In Horses
• In Dogs

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion